Details of the Drug

General Information of Drug (ID: DMG3FAD)

• Drug Name: Epetirimod
• Synonyms: Epetirimod esylate; Immunomodulator, Takeda; R-851; S-30563; TAK-851; HPV/cervical dysplasia therapy, Takeda; Immunomodulator, 3M/Takeda; HPV/cervical dysplasia therapy, 3M/Takeda; S-30563-35-65; 851A; 851B; 851B gel

Indication

Disease Entry	ICD 11	Status	REF
Virus infection	1A24-1D9Z	Phase 2	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C13H15N5
  Canonical SMILES: CC(C)CN1C=NC2=C1C3=C(C=CC=N3)N=C2N
  InChI: InChI=1S/C13H15N5/c1-8(2)6-18-7-16-11-12(18)10-9(17-13(11)14)4-3-5-15-10/h3-5,7-8H,6H2,1-2H3,(H2,14,17)
  InChIKey: UCPMSMNKGXUFCC-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 9942845
  CAS Number: 227318-71-0
  DrugBank ID: DB05747
  TTD ID: D0ET2S

References

• [1] ClinicalTrials.gov (NCT00312286) Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.. U.S. National Institutes of Health.